Dr. Hall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-606-7222- Is this information wrong?
Education & Training
- Stanford Health CareFellowship, Hematology and Medical Oncology, 2016 - 2019
- Stanford Health Care-Sponsored Stanford UniversityChief Residency, Internal Medicine, 2015 - 2016
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2012 - 2015
- University of California San Diego School of MedicineClass of 2012
- University of CambridgeM.Phil., Biological Sciences, 2007 - 2008
- Pomona CollegeBA, Chemistry, 2003 - 2007
Certifications & Licensure
- WA State Medical License 2019 - 2025
- MT State Medical License 2022 - 2024
- ID State Medical License 2022 - 2024
- AK State Medical License 2022 - 2024
- CA State Medical License 2013 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Correction to: Extended duration of treatment using reduced‑frequency dosing of anti‑PD‑1 therapy in patients with advanced melanoma and Merkel cell carcinoma.Lisa May Ling Tachiki, Daniel S Hippe, Karly Williams Silva, Evan Thomas Hall, William McCamy, Dane Fritzsche, Andrea Perdue, Julia Majovski, Thomas Pulliam, Daniel A ...> ;Cancer Immunology, Immunotherapy. 2023 Dec 1
- 1 citationsExtended duration of treatment using reduced-frequency dosing of anti-PD-1 therapy in patients with advanced melanoma and Merkel cell carcinoma.Lisa May Ling Tachiki, Daniel S Hippe, Karly Williams Silva, Evan Thomas Hall, William McCamy, Dane Fritzsche, Andrea Perdue, Julia Majovski, Thomas Pulliam, Daniel A ...> ;Cancer Immunology, Immunotherapy. 2023 Nov 1
- The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma.Andrew B Barbour, Simon Kirste, Anca-Liga Grosu, Shankar Siva, Alexander V Louie, Hiroshi Onishi, Anand Swaminath, Bin S Teh, Sarah P Psutka, Emily S Weg, Jonathan J C...> ;Cancers. 2023 Jul 19
- Join now to see all
Press Mentions
- 6 Steps to Take After a Kidney Cancer DiagnosisJune 11th, 2023
Hospital Affiliations
- Fred Hutchinson Cancer CenterSeattle, Washington
- UW Medicine/University of Washington Medical CenterSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: